tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 71 are a BUY (70.3%), 30 are a HOLD (29.7%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 38.15% that have a potential upside of 62.75% achieved within 137 days.
Kalpit Patel’s has documented 200 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRBP, Corbus Pharmaceuticals at 30-Jul-2025.
Analyst best performing recommendations are on GERN (GERON).
The best stock recommendation documented was for GERN (GERON) at 2/27/2025. The price target of $2 was fulfilled within 1 day with a profit of $0.37 (15.61%) receiving and performance score of 156.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$2.56 (34.41%)
$22
10 days ago
(12-Aug-2025)
1/13 (7.69%)
$2.78 (38.50%)
174
Hold
$13
$5.56 (74.73%)
$17
10 days ago
(12-Aug-2025)
0/7 (0%)
$5.78 (80.06%)
Buy
$44
$36.56 (491.40%)
$48
11 days ago
(11-Aug-2025)
3/9 (33.33%)
$36.54 (489.81%)
192
Hold
$14
$6.56 (88.17%)
$17
3 months 20 days ago
(02-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Buy
$29
$21.56 (289.78%)
$30
3 months 20 days ago
(02-May-2025)
0/21 (0%)
$19.7 (211.83%)
Which stock is Kalpit Patel is most bullish on?
Which stock is Kalpit Patel is most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
